Cargando…
Phase I safety study of 0.5% PRO 2000 vaginal Gel among HIV un-infected women in Pune, India
BACKGROUND: The objective of this study was to evaluate the safety of twice daily, intra-vaginal use of 0.5% PRO 2000 Gel for fourteen days in HIV un-infected women at lower as well as higher risk for HIV acquisition, in Pune, India. METHODS: Forty-two eligible volunteers (30 low-risk and 12 high-ri...
Autores principales: | Smita, Joshi, Soma, Dutta, Beverly, Bell, Albert, Profy, JoAnn, Kuruc, Fang, Gai, Missy, Cianciola, Lydia, Soto-Torres, Anjali, Panchanadikar, Arun, Risbud, Sanjay, Mehendale, Steven J, Reynolds |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435917/ https://www.ncbi.nlm.nih.gov/pubmed/16504023 http://dx.doi.org/10.1186/1742-6405-3-4 |
Ejemplares similares
-
Antimicrobial susceptibility of Neisseria gonorrhoeae in Pune from 1996 to 2007
por: Kulkarni, Sangeeta, et al.
Publicado: (2011) -
Mortality in HIV infected individuals in Pune, India
por: Ghate, Manisha, et al.
Publicado: (2011) -
Postcoital Bioavailability and Antiviral Activity of 0.5% PRO 2000 Gel: Implications for Future Microbicide Clinical Trials
por: Keller, Marla J., et al.
Publicado: (2010) -
HPV Genotype Distribution in Cervical Intraepithelial Neoplasia among HIV-Infected Women in Pune, India
por: Mane, Arati, et al.
Publicado: (2012) -
Genotype-specific incidence and clearance rates of human papilloma virus (HPV) infection in HIV-infected women from Pune, India
por: Mane, Arati, et al.
Publicado: (2012)